Copyright Reports & Markets. All rights reserved.

Global Mantle Cell Lymphoma Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Mantle Cell Lymphoma Treatment Market Overview

      • 1.1 Product Overview and Scope of Mantle Cell Lymphoma Treatment
      • 1.2 Mantle Cell Lymphoma Treatment Segment by Type
        • 1.2.1 Global Mantle Cell Lymphoma Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Acalabrutinib
        • 1.2.3 JCAR-017
        • 1.2.4 JNJ-64052781
        • 1.2.5 Acalisib
        • 1.2.6 IGN-002
        • 1.2.7 IMGN-529
        • 1.2.8 AFM-11
        • 1.2.9 Others
      • 1.3 Mantle Cell Lymphoma Treatment Segment by Application
        • 1.3.1 Mantle Cell Lymphoma Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.3 Global Mantle Cell Lymphoma Treatment Market by Region
        • 1.3.1 Global Mantle Cell Lymphoma Treatment Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Mantle Cell Lymphoma Treatment Market Size
        • 1.4.1 Global Mantle Cell Lymphoma Treatment Revenue (2014-2025)
        • 1.4.2 Global Mantle Cell Lymphoma Treatment Production (2014-2025)

      2 Global Mantle Cell Lymphoma Treatment Market Competition by Manufacturers

      • 2.1 Global Mantle Cell Lymphoma Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Mantle Cell Lymphoma Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Mantle Cell Lymphoma Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Mantle Cell Lymphoma Treatment Production Sites, Area Served, Product Types
      • 2.5 Mantle Cell Lymphoma Treatment Market Competitive Situation and Trends
        • 2.5.1 Mantle Cell Lymphoma Treatment Market Concentration Rate
        • 2.5.2 Mantle Cell Lymphoma Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Mantle Cell Lymphoma Treatment Production Market Share by Regions

      • 3.1 Global Mantle Cell Lymphoma Treatment Production Market Share by Regions
      • 3.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Mantle Cell Lymphoma Treatment Production
        • 3.4.1 North America Mantle Cell Lymphoma Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Mantle Cell Lymphoma Treatment Production
        • 3.5.1 Europe Mantle Cell Lymphoma Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Mantle Cell Lymphoma Treatment Production (2014-2019)
        • 3.6.1 China Mantle Cell Lymphoma Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Mantle Cell Lymphoma Treatment Production (2014-2019)
        • 3.7.1 Japan Mantle Cell Lymphoma Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Mantle Cell Lymphoma Treatment Consumption by Regions

      • 4.1 Global Mantle Cell Lymphoma Treatment Consumption by Regions
      • 4.2 North America Mantle Cell Lymphoma Treatment Consumption (2014-2019)
      • 4.3 Europe Mantle Cell Lymphoma Treatment Consumption (2014-2019)
      • 4.4 China Mantle Cell Lymphoma Treatment Consumption (2014-2019)
      • 4.5 Japan Mantle Cell Lymphoma Treatment Consumption (2014-2019)

      5 Global Mantle Cell Lymphoma Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Mantle Cell Lymphoma Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Mantle Cell Lymphoma Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Mantle Cell Lymphoma Treatment Price by Type (2014-2019)
      • 5.4 Global Mantle Cell Lymphoma Treatment Production Growth by Type (2014-2019)

      6 Global Mantle Cell Lymphoma Treatment Market Analysis by Applications

      • 6.1 Global Mantle Cell Lymphoma Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Mantle Cell Lymphoma Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Mantle Cell Lymphoma Treatment Business

      • 7.1 Astex Pharmaceuticals, Inc.
        • 7.1.1 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.1.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.1.3 Astex Pharmaceuticals, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Bayer AG
        • 7.2.1 Bayer AG Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.2.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.2.3 Bayer AG Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Bristol-Myers Squibb Company
        • 7.3.1 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.3.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.3.3 Bristol-Myers Squibb Company Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Celgene Corporation
        • 7.4.1 Celgene Corporation Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.4.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.4.3 Celgene Corporation Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Cellular Biomedicine Group, Inc.
        • 7.5.1 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.5.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.5.3 Cellular Biomedicine Group, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Eisai
        • 7.6.1 Eisai Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.6.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.6.3 Eisai Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 EpiZyme, Inc.
        • 7.7.1 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.7.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.7.3 EpiZyme, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Fate Therapeutics, Inc.
        • 7.8.1 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.8.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.8.3 Fate Therapeutics, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Genentech, Inc.
        • 7.9.1 Genentech, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.9.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.9.3 Genentech, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Gilead Sciences, Inc.
        • 7.10.1 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Production Sites and Area Served
        • 7.10.2 Mantle Cell Lymphoma Treatment Product Introduction, Application and Specification
        • 7.10.3 Gilead Sciences, Inc. Mantle Cell Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 GlaxoSmithKline Plc
      • 7.12 Hutchison MediPharma Limited
      • 7.13 ImmunoGen, Inc.
      • 7.14 Immunomedics, Inc.

      8 Mantle Cell Lymphoma Treatment Manufacturing Cost Analysis

      • 8.1 Mantle Cell Lymphoma Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Mantle Cell Lymphoma Treatment
      • 8.4 Mantle Cell Lymphoma Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Mantle Cell Lymphoma Treatment Distributors List
      • 9.3 Mantle Cell Lymphoma Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Mantle Cell Lymphoma Treatment Market Forecast

      • 11.1 Global Mantle Cell Lymphoma Treatment Production, Revenue Forecast
        • 11.1.1 Global Mantle Cell Lymphoma Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Mantle Cell Lymphoma Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Mantle Cell Lymphoma Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Mantle Cell Lymphoma Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Mantle Cell Lymphoma Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Mantle Cell Lymphoma Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Mantle Cell Lymphoma Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Mantle Cell Lymphoma Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Mantle Cell Lymphoma Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Mantle Cell Lymphoma Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Mantle Cell Lymphoma Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Mantle Cell Lymphoma Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Mantle Cell Lymphoma Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Mantle Cell Lymphoma Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Mantle Cell Lymphoma Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Mantle Cell Lymphoma Treatment market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Mantle Cell Lymphoma Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mantle Cell Lymphoma Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Astex Pharmaceuticals, Inc.
        Bayer AG
        Bristol-Myers Squibb Company
        Celgene Corporation
        Cellular Biomedicine Group, Inc.
        Eisai
        EpiZyme, Inc.
        Fate Therapeutics, Inc.
        Genentech, Inc.
        Gilead Sciences, Inc.
        GlaxoSmithKline Plc
        Hutchison MediPharma Limited
        ImmunoGen, Inc.
        Immunomedics, Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Acalabrutinib
        JCAR-017
        JNJ-64052781
        Acalisib
        IGN-002
        IMGN-529
        AFM-11
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now